DexCom (NASDAQ:DXCM – Get Rating) and Axonics (NASDAQ:AXNX – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings and price targets […]
DexCom (NASDAQ:DXCM – Get Rating) released its earnings results on Thursday. The medical device company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02, Briefing.com reports. DexCom had a net margin of 9.68% and a return on equity of 18.65%. The business had revenue of $7.45 billion during the quarter, […]
Retirement Systems of Alabama lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 123,743 shares of the medical device company’s stock after selling 6,652 shares during the period. Retirement Systems […]
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) hit a new 52-week high on Thursday following a stronger than expected earnings report. The company traded as high as $126.44 and last traded at $121.69, with a volume of 325550 shares. The stock had previously closed at $124.93. The medical device company reported $0.17 earnings per […]
TCI Wealth Advisors Inc. lifted its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 36.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 762 shares of the medical device company’s stock after acquiring an additional 204 shares during the period. TCI Wealth Advisors Inc.’s holdings […]